Grundinformationen
- CAS
25905-77-5- Standard-SMILES
Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1- InChIKey
LDMWSLGGVTVJPG-UHFFFAOYSA-N- Summenformel
- C17H22N4O
- Durchschnittliche Molmasse
- 298,4 g/mol
- Monoisotopische Masse
- 298,17936134
Überblick
Minaprine is a secondary amine, a member of pyridazines and a member of morpholines. It has a role as an antidepressant, a cholinergic drug, an antiparkinson drug, a serotonin uptake inhibitor and a dopamine uptake inhibitor.
Namen und Bezeichner
- Bevorzugter Name
- Minaprine
- IUPAC
- 4-methyl-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine
- Lokaler Name
- Minaprin
- Englischer Name
- Minaprine dihydrochloride
- Summenformel
- C17H22N4O
- Molmasse
- 298.38
Namen und Synonyme
minaprine25905-77-5CantorMinaprinaMinaprinumAGR 1240N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamineAgr-12404-Morpholineethanamine, N-(4-methyl-6-phenyl-3-pyridazinyl)-4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazinCB 300384-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine
Weitere Namen anzeigen
TS-370minaprinMinaprin diHClMinaprine 2HClMINAPRINE HYDROCHLORIDEMINAPRIN DIHYDROCHLORIDE
4-methyl-N-[2-(morpholin-4-yl)ethyl]-6-phenylpyridazin-3-amine00U7GX0NLMCB-30038DTXSID5048477CHEBI:510384-[2-[(4-Methyl-6-phenyl-3-pyridazinyl)amino]ethyl]morpholine4-methyl-N-(2-(morpholin-4-yl)ethyl)-6-phenylpyridazin-3-amine3-(morpholinoethyl)amino-4-methyl-6-phenylpyridazine
Datenbank-Bezeichner
- CAS
25905-77-5- PubChem CID
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2
- Polarare Oberfläche (TPSA)
- 50,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 5
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 316
Experimentelle und physikochemische Eigenschaften
DrugsPharmaceuticals -> Listed in ZINC15
LogP
2
2.03
Solubility7.01e-02 g/L
Melting Point122 °C
Physical DescriptionSolid
Collision Cross Section172.37 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physikochemische Eigenschaften
- Schmelzpunkt
- 122 ° · 122°
- Siedepunkt
- 531.2 · 531.2±50.0 °C(Predicted)
- Dichte
- 1.156 · 1.156±0.06 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- 35 mg/mL · DMSO : ≥ 35 mg/mL (117.30 mM)
- pka
- 6.8 · 6.80±0.10(Predicted)
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- wgk
- 3
- RTECS-Nr.
- QE3477830
- risk_code
- 22
- hazard_code
- Xn
- safety_code
- 36
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Acute Tox. 4 Oral
Chemie und Industrie
Pharmakologische Informationen
ATC Code
N - Nervous system
QN - Nervous system
Pharmacodynamics
Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. Similar to other antidepressant treatments, minaprine attenuates the beta-adrenergic receptor function. Studies have also shown that minaprine improves memory consolidation and that repeated drug administration leads to potentiation of this effect. Moreover, the effects of minaprine on memory consolidation are related to its dopaminergic action.
Mechanism of Action
Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of MAO-A (RIMA).It has also been found to inhibit acetylcholinesterase.
Metabolism/Metabolites
Hepatic. Cytochrome P4502D is responsible for the 4-hydroxylation of minaprine to 4-hydroxyminaprine.
Minaprine has known human metabolites that include 4-Hydroxyminaprine.
MeSH Pharmacological Classification
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
Cellular LocationsCytoplasm
Anwendungen
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…